Practice guidelines are important tools for improving the delivery of evidence-based practices and reducing inappropriate variation in current treatment approaches. This study examined the degree to which guidelines targeted to the treatment of substance use disorders or serious mental illness address treatment of co-occurring disorders. Guidelines archived by the National Guideline Clearinghouse (NGC) were retrieved in December 2007 and content analyzed. Nineteen pertinent guidelines were identified, and 11 included recommendations regarding the assessment and/or treatment of co-occurring disorders. None of the guidelines making recommendations for treatment of co-occurring disorders included outcomes that clearly targeted both substance use and mental health disorders. Limitations and implications of this study are noted.
Introduction
Substance use disorders (SUDs) and serious mental illnesses (SMIs) are significant public health concerns. Approximately 22 million people in the United States were classified with substance use or dependence in the past year (Epstein, Barker, Vorburger, and Murtha, 2004) and 44 million people have experienced a SMI within the past year (National Institute of Mental Health, 2001 ; US Department of Health and Human Services, 1999) . Furthermore, the Substance Abuse and Mental Health Services Administration (SAMHSA) estimated in 1997 that the United States expended roughly $85 billion for these disorders, and 56% of this amount was from public sources in that year alone (Mark, 2003; Mark et al., 2000) .
The emergence of translational research is a direct result of increased awareness of the pressing need to improve the system of care for dually diagnosed clients. Treatment guidelines are important components of broader strategies for moving research into practice and changing provider practice patterns (Grimshaw et al., 2001 . Treatment guidelines are the systematically compiled statements of empirically tested knowledge and recommended practices designed to help practitioners and clients select appropriate interventions for specific clinical circumstances (Proctor and Rosen, 2003; Rosen and Proctor, 2003) . A key function of guidelines is to promote effective decision-making in situations that are frequently encountered by service providers and their clients (Eddy, 1996) . Clinical practice guidelines have received considerable attention in the literature on evidence-based practices and are one of the major tools for reducing treatment variability and translating research into practice (Howard and Jensen, 1999; Institute of Medicine, 2006; Rosen and Proctor, 2003; Walker, Howard, Lambert, and Suchinsky, 1994; Walker, Howard, Walker, Lambert, and Suchinsky, 1995) .
Research Objectives
Using a public open-access database of treatment guidelines, this study examined the extent to which current guidelines targeting either SUDs or SMIs also addressed co-occurring disorders. Co-occurring disorders are associated with a wide range of problems requiring the attention of service providers from various disciplines. Therefore, this study also examined the outcomes and intended audience targeted in guidelines that address co-occurring SUDS and SMIs.
Methods

Data Source
This study examined guidelines archived by the National Guideline Clearinghouse (NGC; http://www.guidelines.gov/), which is a public, open-access database of treatment guidelines. The NGC is sponsored by the Agency for Healthcare Research and Quality (AHRQ) of the US Department of Health and Human Services. It was originally created by AHRQ in partnership with the American Medical Association and the American Association of Health Plans (now America's Health Insurance Plans). Advantages of this resource are that guidelines are presented in a standardized format, located in a single database, and freely available, thereby reducing the burden of searching for and retrieving guidelines. The NGC is the only coordinated effort to organize and disseminate practice guidelines in this fashion. This database also contains guidelines produced by the major health-related organizations, including the American Medical Association, the American Psychiatric Association, and the Department of Veterans Affairs. At the time of writing this report, the database included 2,264 guidelines.
Search Definitions
In this study, "substance use disorders" included abuse or dependence based on the criteria of the DSM-IV-TR (American Psychiatric Association, 2000). "Substances" of abuse were alcohol and those psychoactive drugs identified in DSM-IV-TR . The specific SMIs targeted in this study were those associated with significant disability and that were widely prevalent and commonly treated within the public mental health system: schizophrenia-spectrum disorders, bipolar disorder, and major depression (Drake et al., 2001) . "Co-occurring disorders" referred to the simultaneous presentation of a substance use disorder and a serious mental illness. This usage is synonymous with other commonly used terms such as "dual diagnosis," "dual disorders," "co-morbidity," and "coexisting disorders."
Search Procedures
A computerized bibliographic search for guidelines of the NGC database was conducted on December 1, 2007. The NGC database does not provide the facilities to conduct complex searches containing Boolean operators. Thus, the procedure involved a broad-based search using the following key words: "substance abuse," "bipolar disorder," "depression," and "schizophrenia." This search procedure proved to be comprehensive. Specifically, it returned guidelines that were relevant to the study purpose and numerous guidelines that were irrelevant. The search strategy also returned a large number of duplicate guidelines. For example, the search for schizophrenia guidelines returned many depression guidelines. Subsequent searches using other synonymous keywords (e.g., major depressive disorder, psychosis, schizoaffective disorder, substance dependence, drug abuse) did not return additional unique guidelines. Finally, a search for guidelines targeting "co-occurring disorders" and its various synonyms (e.g., dual diagnosis, dual disorders, co-morbidity, and coexisting disorders) did not produce any additional unique guidelines.
A preliminary review indicated that the available guidelines for SUDs and SMIs were very heterogenous, targeting a variety of different populations and multiple disorders. In order to produce a set of guidelines that were comparable with respect to study aims, a set of inclusion and exclusion criteria was applied. Each criterion and the number of guidelines excluded at each step are summarized in Table 1 . The criteria and justification are as follows. Guidelines were limited to adult treatment (age 17 to 44 years), given the prevalence of the disorders and treatment varies considerably with different age groups. Guidelines were excluded if they were not published by a US organization, since the system of care can largely determine the treatment possibilities. Guidelines were also excluded if they did not specifically address the target SUDs or SMIs as primary disorders. For example, guidelines were excluded that considered SUDs or SMIs as secondary conditions associated with other primary medical or social conditions (e.g., spinal cord injury, cardiovascular disease, and domestic violence). As this study focused on interdisciplinary guidelines, guidelines focusing specifically on medication management were also excluded from the review.
After excluding duplicate guidelines, the complete guidelines were downloaded as portable document files (PDFs) and reviewed. The full list of search results was compiled and the titles and summaries of each guideline were reviewed.
Coding
Guidelines were examined to determine whether they provided any treatment or screening recommendations regarding co-occurring disorders. Treatment recommendations included any clinical or psychosocial interventions specifically targeting co-occurring disorders. Screening recommendations included any diagnostic or assessment procedures for cooccurring disorders. Intended users of guidelines were categorized into two types: (1) medical professionals (physicians, nurses, advanced practice nurses, pharmacists, physician assistants, and other health care providers); (2) behavioral health clinicians (social workers, psychologists, other mental health professionals, and substance use disorder treatment providers). The different types of major outcomes targeted by each treatment guideline were recorded as written.
Results
Recommendations for Co-Occurring Disorders
A total of 19 unique treatment guidelines were retrieved from the NGC database; nine guidelines targeted SUDs and 10 targeted SMIs. These guidelines and their full citations are provided in Appendix purposes of brevity, guidelines cited in the text are referred to by the letter preceding the abbreviation in this Appendix.
Of the total guidelines, slightly more than half (58%, N = 11) contained at least one recommendation with respect to assessment and/or treatment of co-occurring disorders (see Table 2 ). While SMI guidelines had a higher proportion of co-occurring recommendations than SUD guidelines (64% versus 55%, respectively), these differences were not significant based on a Fisher's exact test (p = .41). Bipolar disorder was the only type of disorder for which there were no guidelines containing recommendations for a co-occurring disorder. Across all guidelines that addressed co-occurring disorders, the most common recommendation was for screening/assessment, which was present in 64% (N = 7) of the guidelines (Guidelines D, B, G, H, M, O, P, Q). Forty-five (N = 5) of the guidelines recommended a referral to a provider in the other (i.e., SUD or SMI) sector of care (Guidelines G, M, O, P, R). Four guidelines recommended collaboration or cooperation across sectors (Guidelines C, B, G, O), and one guideline recommended integrated SUD and SMI treatment (Guideline R). It should be noted that two guidelines recommended "treatment" (Guidelines H, Q), but additional information was not specified in terms of how treatment should be conducted (e.g., collaboratively or in an integrated approach).
Multidisciplinary Guidelines
Medical professionals were the intended users of all 11 treatment guidelines that addressed co-occurring disorders. Of these 11 guidelines, all but three (Guidelines O, Q, R) also listed behavioral health professionals as intended users. Specifically, all guidelines for SUDs that included recommendations for co-occurring disorders targeted both medical and behavioral health providers. However, behavioral health providers were not listed as intended users on two SMI guidelines for depression guidelines (Guideline O, Q) and one SMI guideline for schizophrenia/psychosis (Guideline R).
Treatment Outcomes
With the exception of one (Guideline O), all guidelines listed treatment outcomes. The number of outcomes targeted in these guidelines containing recommendations for cooccurring disorders ranged from 3 to 11 (Mean = 5.9, SD = 3.0). Among this set of guidelines, there were no clear outcomes that addressed both psychiatric symptomatology and substance abuse-related outcomes, such as relapse. Three SMI guidelines that addressed co-occurring disorders in some fashion referred to relapse (Guidelines M, P, S) but did not indicate whether relapse referred to the SMI, SUD, or both. All guidelines that addressed cooccurring disorders and described treatment outcomes targeted at least one psychosocial outcome beyond clinical outcomes.
Discussion
This study reviewed the degree to which guidelines for SMIs and SUDs archived by the National Guidelines Clearinghouse addressed treatment for co-occurring disorders. Slightly more than half of the total guidelines retrieved included some type of recommendation for the treatment of co-occurring disorders. These recommendations included assessment, referrals, and collaboration with other professionals in the other sector of care. With the exception of two guidelines (described below), these recommendations contained minimal elaboration or specificity, leaving considerable room for interpretation on how the recommendations should actually be implemented in routine practice.
Two guidelines are particularly noteworthy with respect to their specificity regarding treatment for co-occurring disorders. This included the treatment guideline for schizophrenia, authored by the American Psychiatric Association (Guideline R). This guideline provided a comprehensive description of the major features of treatment (e.g., case management, family interventions, rehabilitation, pharmacotherapy, and housing) and noted the importance of the same clinicians treating both the SMI and SUD. Overall, these recommendations are consistent with the broader literature on comprehensive and integrated treatment for this population (Drake et al., 1998 (Drake et al., , 2001 ). It should be noted that the treatment guideline for bipolar disorder, also authored by the American Psychiatric Association (Guideline J), did not contain any treatment recommendations regarding SUDs. This is a surprising finding, given the evidence suggesting that the rates of co-occurring alcohol and drug problems among persons with bipolar disorder are at least equal to or greater than the rates among persons with schizophrenia (Robins and Regier, 1991) .
The second guideline to address treatment targeted substance use disorders with cooccurring psychiatric disorders (Guideline B). This is a comprehensive treatment guideline that contains screening suggestions, essential components of treatment (e.g., psychoeducation, double trouble groups, and community-based dual recovery mutual self-help groups), and treatment strategies (e.g., motivational interviewing, contingency management, relapse prevention, and assertive community treatment). This guideline also corresponds to a larger treatment manual provided by the Center for Substance Abuse Treatment (2005).
The majority of the guidelines targeting co-occurring disorders were intended for a multidisciplinary audience of service providers. This reflects the wide recognition that treating SUDs, SMIs, and these conditions as they co-occur requires coordination with many different provider types. However, the outcomes targeted by the guidelines were generally restricted to the primary focus of the single disorder, even though the assessment and/or treatment issues addressed co-occurring disorders. This suggests that many of these guidelines have limited utility for addressing the full range of problems and needs that are commonly encountered among persons with co-occurring disorders.
Limitations and Generalizability
This systematic review was restricted to guidelines archived on the NGC. This excluded a potentially large number of proprietary and nonproprietary guidelines that are available in print and electronically. Thus, the generalizability of this study is limited. Additionally, it was beyond the scope of this study to examine the quality and consistency of the recommendations contained in the guidelines against the extant literature. Despite these limitations, it is important to emphasize that the NGC remains as one of the largest (or the largest) data base that provides readily obtainable guidelines from major organizations that are free.
Conclusions
Treatment guidelines can play an important role in implementing evidence-based practices and changing provider practice patterns. Two guidelines that provide very specific information for treating co-occurring disorders were located. Although the current guidelines are limited, the NGC provides an infrastructure that makes guidelines widely available without charge. Additional efforts are needed to improve existing guidelines to better address co-occurring disorders. Without such guidelines, practitioners may fail to screen for and identify the presence of co-occurring SUDs and SMIs. Furthermore, in addition to screening, comprehensive empirically based treatment guidelines are necessary to inform practitioners of integrated treatment methods. As existing research suggests, outcomes for primary presenting disorders are likely to be improved through proper screening and treatment (Baethge et al., 2005; Haywood et al., 1995; Mangrum, Spence, and Lopez, 2006; Sacks, McKendrick, Sacks, Banks, and Harle, 2007) . Additional research is also needed to better understand and overcome barriers related to the implementation of treatment guidelines and other forms of evidence-based practice (see Grimshaw, Eccles, and Tetroe, 2004) .
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